Llwytho...
Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases
INTRODUCTION: Trastuzumab therapy significantly improves progression-free and overall survival in HER2-positive [HER2(+)] breast cancer (BC) patients. However, in most patients with HER2(+) metastatic BC, the disease progress occurred. The aim of this study was to evaluate the clinicopathological ri...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Prz Menopauzalny |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Termedia Publishing House
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4612553/ https://ncbi.nlm.nih.gov/pubmed/26528105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pm.2015.54341 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|